Creative Structures for Keeping Innovation Alive After the Deal
Monday, June 03, 2024
Breakout Session
![Business Development and Finance](https://cdn.asp.events/CLIENT_BIO_7BB99CBA_BAD1_B8C8_CF9F25DA29A80CC6/sites/BIOIC-2024/media/icons/seminars/BIO-track-icon_Busines_MTC.png)
29AB
Life sciences transactions often focus on innovation and keeping that innovation alive is critical to ongoing success. In this panel, panelists will explore several different M&A and licensing models for keeping the innovation engine going including: acquired companies operating independently; option deals that maintain autonomy up to a certain development phase; milestone payments and contingent value rights; and employee retention plans. The session will engage our esteemed panelists from the pharma and biotech sectors, on their and their companies’ experiences and lessons learned, including a discussion on the M&A and licensing tactics that have been most successful.
Moderator
Speakers